keyword
https://read.qxmd.com/read/38652779/preventing-staphylococci-surgical-site-infections-with-a-nitric-oxide-releasing-poly-lactic-acid-co-glycolic-acid-suture-material
#1
JOURNAL ARTICLE
Lauren Griffin, Mark Richard Stephen Garren, Patrick Maffe, Sama Ghalei, Elizabeth J Brisbois, Hitesh Handa
Of the 27 million surgeries performed in the United States each year, a reported 2.6% result in a surgical site infection (SSI), and Staphylococci species are commonly the culprit. Alternative therapies, such as nitric oxide (NO)-releasing biomaterials, are being developed to address this issue. NO is a potent antimicrobial agent with several modes of action, including oxidative and nitrosative damage, disruption of bacterial membranes, and dispersion of biofilms. For targeted antibacterial effects, NO is delivered by exogenous donor molecules, like S -nitroso- N -acetylpenicillamine (SNAP)...
April 23, 2024: ACS Applied Bio Materials
https://read.qxmd.com/read/38652717/lytic-bacteriophages-induce-the-secretion-of-antiviral-and-proinflammatory-cytokines-from-human-respiratory-epithelial-cells
#2
JOURNAL ARTICLE
Paula F Zamora, Thomas G Reidy, Catherine R Armbruster, Ming Sun, Daria Van Tyne, Paul E Turner, Jonathan L Koff, Jennifer M Bomberger
Phage therapy is a therapeutic approach to treat multidrug-resistant (MDR) infections that employs lytic bacteriophages (phages) to eliminate bacteria. Despite the abundant evidence for its success as an antimicrobial in Eastern Europe, there is scarce data regarding its effects on the human host. Here, we aimed to understand how lytic phages interact with cells of the airway epithelium, the tissue site that is colonized by bacterial biofilms in numerous chronic respiratory disorders. Using a panel of Pseudomonas aeruginosa phages and human airway epithelial cells (AECs) derived from a person with cystic fibrosis (CF), we determined that interactions between phages and epithelial cells depend on specific phage properties as well as physiochemical features of the microenvironment...
April 2024: PLoS Biology
https://read.qxmd.com/read/38652686/application-of-mono-and-trinuclear-cyclometalated-iridium-iii-complexes-in-differential-bacterial-imaging-and-antimicrobial-photodynamic-therapy
#3
JOURNAL ARTICLE
Bishnu Das, Prakash Biswas, Amirul Islam Mallick, Parna Gupta
The application of transition metal complexes for antimicrobial photodynamic therapy (PDT) has emerged as an attractive alternative in mitigating a broad range of bacterial pathogens, including multidrug-resistant pathogens. In view of their photostability, long excited-state lifetimes, and tunable emission properties, transition metal complexes also contribute as bioimaging agents. In the present work, we designed mono and trinuclear cyclometalated iridium(III) complexes to explore their imaging application and antibacterial potential...
April 23, 2024: Chemistry: a European Journal
https://read.qxmd.com/read/38652457/genome-scale-model-of-rothia-mucilaginosa-predicts-gene-essentialities-and-reveals-metabolic-capabilities
#4
JOURNAL ARTICLE
Nantia Leonidou, Lisa Ostyn, Tom Coenye, Aurélie Crabbé, Andreas Dräger
Cystic fibrosis (CF), an inherited genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator gene, results in sticky and thick mucosal fluids. This environment facilitates the colonization of various microorganisms, some of which can cause acute and chronic lung infections, while others may positively impact the disease. Rothia mucilaginosa , an oral commensal, is relatively abundant in the lungs of CF patients. Recent studies have unveiled its anti-inflammatory properties using in vitro three-dimensional lung epithelial cell cultures and in vivo mouse models relevant to chronic lung diseases...
April 23, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38652455/supportive-care-measures-for-bispecific-t-cell-engager-therapies-in-haematological-malignancies
#5
JOURNAL ARTICLE
Lucia Y Chen, Jaimal Kothari
PURPOSE OF REVIEW: Bispecific T-cell engager (TCE) therapies are revolutionizing the treatment of several haematological malignancies, including B-cell acute lymphoblastic leukaemia, various subtypes of B-cell non-Hodgkin lymphoma, and multiple myeloma. Due to their unique mode of action in activating endogenous T cells, they are associated with several important early side effects, including cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, as well as target-specific toxicities and a significant risk of infection...
April 23, 2024: Current Opinion in Supportive and Palliative Care
https://read.qxmd.com/read/38651882/novel-antimony-based-antimicrobial-drug-targets-membranes-of-gram-positive-and-gram-negative-bacterial-pathogens
#6
JOURNAL ARTICLE
Tarosha Salpadoru, Kevin E Pinks, Jacob A Lieberman, Kaitlyn Cotton, Karen L Wozniak, Nikolay Gerasimchuk, Marianna A Patrauchan
UNLABELLED: Antimicrobial resistance (AMR) poses a significant worldwide public health crisis that continues to threaten our ability to successfully treat bacterial infections. With the decline in effectiveness of conventional antimicrobial therapies and the lack of new antibiotic pipelines, there is a renewed interest in exploring the potential of metal-based antimicrobial compounds. Antimony-based compounds with a long history of use in medicine have re-emerged as potential antimicrobial agents...
April 23, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38651875/effects-of-sub-inhibitory-concentrations-of-nafcillin-vancomycibipn-ciprofloxacin-and-rifampin-on-biofilm-formation-of-clinical-methicillin-resistant-staphylococcus-aureus
#7
JOURNAL ARTICLE
Ki-Ho Park, Dokyoung Kim, Minji Jung, Dong Youn Kim, Yu-Mi Lee, Mi Suk Lee, Kyung-Wook Hong, In-Gyu Bae, Sun In Hong, Oh-Hyun Cho
UNLABELLED: Methicillin-resistant Staphylococcus aureus (MRSA) infections are often difficult to treat because of their biofilm-forming ability and antimicrobial resistance. We investigated the effects of sub-minimal inhibitory concentrations (MICs) of antibiotics on MRSA biofilm formation. Clinical MRSA isolates were grown with sub-MICs (1/256-1/2 × MICs) of nafcillin, vancomycin, ciprofloxacin, and rifampin. The biofilm biomass was measured using crystal violet staining. Of the 107 MRSA isolates tested, 63 (58...
April 23, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38651855/altered-serine-metabolism-promotes-drug-tolerance-in-mycobacterium-abscessus-via-a-whib7-mediated-adaptive-stress-response
#8
JOURNAL ARTICLE
Célia Bernard, Yi Liu, Gérald Larrouy-Maumus, Christophe Guilhot, Kaymeuang Cam, Christian Chalut
Mycobacterium abscessus is an emerging opportunistic pathogen responsible for chronic lung diseases, especially in patients with cystic fibrosis. Treatment failure of M. abscessus infections is primarily associated with intrinsic or acquired antibiotic resistance. However, there is growing evidence that antibiotic tolerance, i.e., the ability of bacteria to transiently survive exposure to bactericidal antibiotics through physiological adaptations, contributes to the relapse of chronic infections and the emergence of acquired drug resistance...
April 23, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38651137/hepatitis-c-virus-antiviral-drug-resistance-and-salvage-therapy-outcomes-across-australia
#9
JOURNAL ARTICLE
Dao Sen Wang, Amy Phu, Kristen McKee, Simone I Strasser, Sinead Sheils, Martin Weltman, Sue Sellar, Joshua S Davis, Mel Young, Alicia Braund, Geoffrey C Farrell, Anne Blunn, Damian Harding, Lucy Ralton, Kate Muller, Scott A Davison, David Shaw, Marnie Wood, Krispin Hajkowicz, Richard Skolen, Jane Davies, Jaclyn Tate-Baker, Adam Doyle, Rhoda Tuma, Simon Hazeldine, Wendy Lam, Natalie Edmiston, Krista Zohrab, William Pratt, Belinda Watson, Amany Zekry, Carlie Stephens, Paul J Clark, Melany Day, Gordon Park, Hami Kim, Mark Wilson, Bruce McGarity, Natalie Menzies, Darren Russell, Thao Lam, Peter Boyd, Jen Kok, Jacob George, Mark W Douglas
BACKGROUND: Hepatitis C virus (HCV) infection can now be cured with well-tolerated direct-acting antiviral (DAA) therapy. However, a potential barrier to HCV elimination is the emergence of resistance-associated substitutions (RASs) that reduce the efficacy of antiviral drugs, but real-world studies assessing the clinical impact of RASs are limited. Here, an analysis of the impact of RASs on retreatment outcomes for different salvage regimens in patients nationally who failed first-line DAA therapy is reported...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38650753/predicting-antibiotic-tolerance-in-hvkp-and-ckp-respiratory-infections-through-biofilm-formation-analysis-and-its-resistance-implications
#10
JOURNAL ARTICLE
Zhongwei Wen, Yiqiang Chen, Tangjuan Liu, Jiahui Han, Yuting Jiang, Ke Zhang
INTRODUCTION: Respiratory infections are a major global health concern, with Klebsiella pneumoniae standing out due to its evolving antibiotic resistance. This study compares the resistance profiles of hypervirulent Klebsiella pneumoniae (hvKP) and classical Klebsiella pneumoniae (cKP), aiming to shed light on their clinical implications. METHODS: We analyzed 86 cases, comprising 42 hvKP and 44 cKP strains, using comprehensive antimicrobial susceptibility testing and clinical data evaluation to assess antibiotic tolerance and resistance mechanisms...
2024: Infection and Drug Resistance
https://read.qxmd.com/read/38650422/-the-use-of-antioxidants-in-combination-therapy-of-chronic-prostatitis
#11
JOURNAL ARTICLE
V Kuzmenko A, A Gyaurgiev T, V Kuzmenko V, A Kuzmenko G
Currently, the significance of the chronic prostatitis (CP) is undoubted. Oxidative stress is considered as one of the standard mechanisms of cellular damage that is associated with inflammatory diseases such as CP. When choosing the combination therapy for this group of patients, a correction of oxidative stress is pathogenetically justified. Literature data about the pathogenetic feasibility and prospects of using a biologically active complex containing flavonoids and carotenoids quercetin, lycopene and naringin as part of the combination treatment of patients with CP are presented in the article...
March 2024: Urologii︠a︡
https://read.qxmd.com/read/38649443/isolation-and-characterisation-of-a-novel-silviavirus-bacteriophage-promising-antimicrobial-agent-against-methicillin-resistant-staphylococcus-aureus-infections
#12
JOURNAL ARTICLE
Varintip Lerdsittikul, Sukanya Apiratwarrasakul, Thassanant Atithep, Patoo Withatanung, Nitaya Indrawattana, Pornpan Pumirat, Somjit Chaiwattanarungruengpaisan, Metawee Thongdee
The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) emphasises the urgent need for novel antimicrobial agents as alternatives to antibiotics. Bacteriophage therapy is one of the most promising antimicrobial strategies. Here, we isolated and comprehensively characterized a novel Staphylococcus phage, vB_SauM_VL10 (VL10), from urban sewage. The VL10 genome displays 141,746 bp of linear double-stranded DNA, containing 193 open reading frames and lacking tRNA, virulence, or antibiotic resistance genes...
April 22, 2024: Scientific Reports
https://read.qxmd.com/read/38649301/large-scale-genomic-survey-with-deep-learning-based-method-reveals-strain-level-phage-specificity-determinants
#13
JOURNAL ARTICLE
Yiyan Yang, Keith Dufault-Thompson, Wei Yan, Tian Cai, Lei Xie, Xiaofang Jiang
BACKGROUND: Phage therapy, reemerging as a promising approach to counter antimicrobial-resistant infections, relies on a comprehensive understanding of the specificity of individual phages. Yet the significant diversity within phage populations presents a considerable challenge. Currently, there is a notable lack of tools designed for large-scale characterization of phage receptor-binding proteins, which are crucial in determining the phage host range. RESULTS: In this study, we present SpikeHunter, a deep learning method based on the ESM-2 protein language model...
January 2, 2024: GigaScience
https://read.qxmd.com/read/38649034/effects-of-lung-inflammation-and-injury-on-pulmonary-tissue-penetration-of-meropenem-and-vancomycin-in-a-model-of-unilateral-lung-injury
#14
JOURNAL ARTICLE
Johannes Geilen, Matthias Kainz, Bernhard Zapletal, Thomas Schweiger, Walter Jäger, Alexandra Maier-Salamon, Markus Zeitlinger, Tanja Stamm, Valentin Ritschl, Silvana Geleff, Marcus J Schultz, Edda Tschernko
OBJECTIVE: Timing and dosing of antimicrobial therapy is key in the treatment of pneumonia in critically ill patients. It is uncertain whether presence of lung inflammation and injury affects tissue penetration of intravenously administered antimicrobial drugs. We determined the effects of lung inflammation and injury on tissue penetration of two commonly used antimicrobial drugs for pneumonia in an established model of unilateral lung injury. METHODS: In 13 healthy pigs, unilateral lung injury was induced in the left lung through cyclic rinsing - the right healthy lung served as control...
April 20, 2024: International Journal of Antimicrobial Agents
https://read.qxmd.com/read/38648896/efficacy-and-safety-of-withholding-antimicrobial-therapy-in-children-with-cancer-fever-and-neutropenia-with-a-demonstrated-viral-respiratory-infection-a-randomized-clinical-trial
#15
JOURNAL ARTICLE
J P Torres, C Ibañez, R Valenzuela, S Bahamondes, V De la Maza, M Villarroel, P Coria, V Contardo, A M Álvarez, M Zubieta, V Gutierrez, K Ducasse, D Martínez, M E Santolaya
OBJECTIVES: To validate the efficacy and safety of withholding antimicrobial therapy in a new cohort of children with cancer and febrile neutropenia (FN) having a demonstrated viral respiratory tract infection (RTI). METHODS: Prospective, multicenter, non-inferiority, randomized study, approved by the ethical committee, in children presenting with FN at seven hospitals in Chile, evaluated at admission for diagnosis of bacterial and viral pathogens. Children who were positive for a respiratory virus (RV), negative for a bacterial pathogen and had a favorable evolution after 48-72 hours of antimicrobial therapy were randomized to either maintain or withhold antimicrobial therapy...
April 20, 2024: Clinical Microbiology and Infection
https://read.qxmd.com/read/38647986/mitigating-antimicrobial-resistance-an-approach-to-stewardship-in-canine-urinary-tract-infection
#16
JOURNAL ARTICLE
M A Ensha Lomiya, R Raguvaran, Debabrata Mondal, Shivangi Dosar, Sonu S Nair, K R Jitha, A R Chandni, Navjot Singh Thakur, Narayani Yadav, Kaveri Jambagi
Urinary tract infection (UTI) caused by antimicrobial resistant bacteria is common in dogs leading to serious health impact in pet animal as well as on human health. Understanding the prevalent uropathogens and their drug susceptibility is essential for limiting the antimicrobial resistance through implementation of stewardship policies. In view of this, present study was envisaged to determine the prevalent bacterial uropathogens and their antibiogram from clinical cases of canine UTI. Urine samples were collected from 35 dogs presented with clinical signs of UTI and a total of 27 bacterial isolates were recovered...
April 22, 2024: Veterinary Research Communications
https://read.qxmd.com/read/38647957/gut-microbes-in-polycystic-ovary-syndrome-and-associated-comorbidities-type-2-diabetes-non-alcoholic-fatty-liver-disease-nafld-cardiovascular-disease-cvd-and-the-potential-of-microbial-therapeutics
#17
REVIEW
Vineet Singh, Kanika Mahra, DaRyung Jung, Jae-Ho Shin
Polycystic ovary syndrome (PCOS) is one of the most common endocrine anomalies among females of reproductive age, highlighted by hyperandrogenism. PCOS is multifactorial as it can be associated with obesity, insulin resistance, low-grade chronic inflammation, and dyslipidemia. PCOS also leads to dysbiosis by lowering microbial diversity and beneficial microbes, such as Faecalibacterium, Roseburia, Akkermenisa, and Bifidobacterium, and by causing a higher load of opportunistic pathogens, such as Escherichia/Shigella, Fusobacterium, Bilophila, and Sutterella...
April 22, 2024: Probiotics and Antimicrobial Proteins
https://read.qxmd.com/read/38647679/ultrasonic-synthesis-of-green-lipid-nanocarriers-loaded-with-scutellaria-barbata-extract-a-sustainable-approach-for-enhanced-anticancer-and-antibacterial-therapy
#18
JOURNAL ARTICLE
Raghu Jetti, Maritza Lucia Vaca Cárdenas, Haider Falih Shamikh Al-Saedi, Shaymaa Abed Hussein, Hussam Abdali Abdulridui, Salah Hassan Zain Al-Abdeen, Usama Kadem Radi, Adnan Hashim Abdulkadhim, Sahar Balkit Hussein, Ahmed Alawadi, Ali Alsalamy
Ultrasonic manufacturing has emerged as a promising eco-friendly approach to synthesize lipid-based nanocarriers for targeted drug delivery. This study presents the novel ultrasonic preparation of lipid nanocarriers loaded with Scutellaria barbata extract, repurposed for anticancer and antibacterial use. High-frequency ultrasonic waves enabled the precise self-assembly of DSPE-PEG, Span 40, and cholesterol to form nanocarriers encapsulating the therapeutic extract without the use of toxic solvents, exemplifying green nanotechnology...
April 22, 2024: Bioprocess and Biosystems Engineering
https://read.qxmd.com/read/38647392/antimicrobial-and-antiviral-nanofibers-halt-co-infection-spread-via-nuclease-mimicry-and-photocatalysis
#19
JOURNAL ARTICLE
Jieran Yao, Zhenhong Luo, Jiaying Lin, Na Meng, Jiangna Guo, Hui Xu, Rongwei Shi, Linhui Zhao, Jiateng Zhou, Feng Yan, Bin Wang, Hailei Mao
The escalating spread of drug-resistant bacteria and viruses is a grave concern for global health. Nucleic acids dominate the drug-resistance and transmission of pathogenic microbes. Here, imidazolium-type poly(ionic liquid)/porphyrin (PIL-P) based electrospun nanofibrous membrane and its cerium (IV) ion complex (PIL-P-Ce) are developed. The obtained PIL-P-Ce membrane exhibits high and stable efficiency in eradicating various microorganisms (bacteria, fungi, and viruses) and decomposing microbial antibiotic resistance genes and viral nucleic acids under light...
April 22, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38647294/pharmacokinetics-and-safety-of-ever206-a-novel-polymyxin-antimicrobial-in-healthy-chinese-subjects
#20
JOURNAL ARTICLE
Size Li, Xu Zhu, Guoying Cao, Jufang Shen, Xu Zhu, Jicheng Yu, Xiaojie Wu, Jufang Wu, Haijing Yang, Nanyang Li, Yingying Hu, Jingjing Wang, Haihui Huang, Jing Zhang
EVER206 (also known as SPR206) is a novel polymyxin analog that has shown in vitro potency and in vivo efficacy against multidrug-resistant (MDR) Gram-negative pathogens. This randomized, double-blinded, placebo-controlled, Phase I study evaluated the safety, tolerability, and pharmacokinetics of EVER206 in healthy Chinese subjects. After single administration of 50-300 mg EVER206, the Cmax ranged from 3.94 to 25.82 mg/L, and the AUC0-inf ranged from 12.42 to 101.67 h·mg/L. The plasma exposure displayed a linear relationship with the dose administered...
April 22, 2024: Antimicrobial Agents and Chemotherapy
keyword
keyword
63660
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.